NVTR News and Press, Nuvectra Corporation From 06/11/19

PLANO, Texas, June 11, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has filed its regulatory submission with the U.S. Food and Drug Administration (FDA) for full-body MR-conditional approval for the Company&...

PLANO, Texas,, May 30, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today preliminary Algovita ® clinical data from its U.S. and EU multi-center, single-arm study demonstrating lead fracture and migration rates that...

PLANO, Texas, May 16, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced that Walter Z. Berger has resigned as Nuvectra’s Chief Operating Officer and Chief Financial Officer to pursue another business opportunity, ...

Nuvectra Corporation (NVTR) Q1 2019 Earnings Conference Call May 1, 2019 4:30 PM Company Participants Tram Bui - The Ruth Group, Investor Relations Fred Parks - Chief Executive Officer Walter Berger - Chief Operating Officer and Chief Financial Officer Paul Hanchin - President ...

Gainers:  Diffusion Pharmaceuticals (NASDAQ: DFFN ) +49% . ARCA biopharma (NASDAQ: ABIO )  +47% . Digimarc Corporation (NASDAQ: DMRC ) +46% . Hudson Technologies (NASDAQ: HDSN ) +23% . InspireMD (NYSEMKT: NSPR ) +17% . Materion Corporation (NYSE: MTRN ) +16% . Precipio (NASD...

Thinly traded micro cap Nuvectra ( NVTR -30.5% ) is down on over four times normal volume following the release of Q1 results that fell shy of consensus. Highlights: More news on: Nuvectra Corporation, Healthcare stocks news, Earnings news and commentary, Stocks on the move, , Read...

Nuvectra Corporation (NASDAQ: NVTR ): Q1 GAAP EPS of -$0.83 misses by $0.17 . More news on: Nuvectra Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...

PLANO, Texas, May 01, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today financial results for the first quarter ended March 31, 2019. Recent Business Highlights Increased Algovita ® revenues 22% YoY to $1...

PLANO, Texas, April 22, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the first quarter ended March 31, 2019 on Wednesday, May 1, 2019 after market close. Nuvectra wi...

Biogen's (BIIG) latest clinical trial failure is a testament to the difficulty in developing drugs for Alzheimer's, which is littered with failures in the last ten years. But other neurology fields have seen major advances recently, one of the leading being with medical devices that use el...